However, some studies have shown that KLF4 expression is associated with poor survival in breast cancer, prostate cancer, colorectal cancer, and skin squamous cell carcinoma, which indicates that KLF4 may be an oncogene [6, 10–12]. Here, KLF4 is linked to colorectal cancer.